Indication
Polyarticular juvenile idiopathic arthritis
Polyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age. Read more about Polyarticular juvenile idiopathic arthritis
216 drugs 94 manufacturers
Drugs that treat it
Common Polyarticular juvenile idiopathic arthritis therapies.
HUMIRA PEN CROHNS-UC-HS START (adalimumab)
HUMIRA PEN PSOR-UVEITS-ADOL HS (adalimumab)
ORENCIA (WITH MALTOSE) (abatacept/maltose)
RASUVO (PF) (methotrexate/PF)
AMJEVITA AUTOINJECTOR (adalimumab-atto)
AMJEVITA(CF) (adalimumab-atto)
AMJEVITA(CF) AUTOINJECTOR (adalimumab-atto)
AMJEVITA(CF) AUTOINJECTOR (adalimumab-atto)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPolyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age.
Primarily affecting the musculoskeletal system, it drives persistent synovial inflammation, effusion, pain, stiffness, and joint swelling that frequently follows a symmetric distribution involving both large joints and small joints of the hands and feet.
The condition is pathologically classified into rheumatoid factor–positive and rheumatoid factor–negative subtypes, with the seropositive form closely resembling adult rheumatoid arthritis and carrying a higher risk of progressive cartilage destruction, bone erosion, and functional impairment.
- nih.gov
Polyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age
- rheumatology.org
Polyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age
- medlineplus.gov
Polyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age Primarily affecting the musculoskeletal system, it drives persistent synovial inflammation, effusion, pain, stiffness, and joint swelling that frequently follows a symmetric distribution involving both large joints and small joints of the hands and feet The condition is pat...
- windhamhospital.org
Primarily affecting the musculoskeletal system, it drives persistent synovial inflammation, effusion, pain, stiffness, and joint swelling that frequently follows a symmetric distribution involving both large joints and small joints of the hands and feet The condition is pathologically classified into rheumatoid factor–positive and rheumatoid factor–negative subtypes, with the seropositive form closely resembling adult rheumatoid arthritis and carrying a higher risk of progressive cartilage destr...
- clevelandclinic.org
Primarily affecting the musculoskeletal system, it drives persistent synovial inflammation, effusion, pain, stiffness, and joint swelling that frequently follows a symmetric distribution involving both large joints and small joints of the hands and feet
Personalize your experience
Follow Polyarticular juvenile idiopathic arthritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.